All times shown are PDT (GMT-7) (San Francisco)
Displaying One Session
Abstract Sessions On-Demand Channel
Oral abstract session
Room
Abstract Sessions On-Demand Channel
Oral abstract session
Introduction
Speaker
Session Name
Room
Abstract Sessions On-Demand Channel
Oral abstract session
Weight gain and hyperglycemia during the dolutegravir transition in Africa
Session Name
Room
Abstract Sessions On-Demand Channel
Oral abstract session
Changes in body mass index over time in persons with and without HIV
Session Name
Room
Abstract Sessions On-Demand Channel
Oral abstract session
Weight gain before and after switch from TDF to TAF
Session Name
Room
Abstract Sessions On-Demand Channel
Oral abstract session
Weight changes after switching to doravirine/lamivudine/TDF in the DRIVE-SHIFT trial
Session Name
Room
Abstract Sessions On-Demand Channel
Oral abstract session
Improved metabolic parameters after switching from TAF-based 3- or 4-drug regimen to the 2-drug regimen of DTG/3TC (dolutegravir/lamivudine): The TANGO study
Speaker
Session Name
Room
Abstract Sessions On-Demand Channel
Oral abstract session
Conclusion
Speaker
Session Name
Room
Abstract Sessions On-Demand Channel